BioMEMS assimilate miniature sensors, actuators, micro-optics, microfluidics, and structural elements with computation and controls for application in the healthcare sector. Microsystems are used in the healthcare sector for numerous applications. These devices improve the performance of medical devices by providing a competitive advantage to medical device manufacturers. For instance, the use of accelerometers has improved the treatment of cardiac diseases. Another instance being the use of MEMS and nanotechnology to improve drug delivery.Ìý
Highlights
The global BioMEMS and Microsystem in Healthcare market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising healthcare costs have necessitated the increase in demand for health monitoring equipment, which are a cheaper alternative to traditional routine check-ups. Sensors can be installed around homes to keep track of daily activities, and any unusual change in activities is reported. Such sensors are also installed, albeit for a shorter period, to monitor sick patients. It provides accurate and reliable data, which helps in health evaluation. This technology can be highly beneficial for the aging population as they can undergo regular checkups and assistance can be provided in a timely manner.
Report Scope
This report aims to provide a comprehensive presentation of the global market for BioMEMS and Microsystem in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioMEMS and Microsystem in Healthcare.
The BioMEMS and Microsystem in Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global BioMEMS and Microsystem in Healthcare market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BioMEMS and Microsystem in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bluechiip
Cepheid
Given Imaging
Integrated Sensing
Segment by Type
BioMEMS
Microsystem
Segment by Application
Microfluidics
Micro Dispensers for Drug Delivery
Low Meters
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BioMEMS and Microsystem in Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 BioMEMS
1.2.3 Microsystem
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Microfluidics
1.3.3 Micro Dispensers for Drug Delivery
1.3.4 Low Meters
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Perspective (2018-2029)
2.2 BioMEMS and Microsystem in Healthcare Growth Trends by Region
2.2.1 Global BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 BioMEMS and Microsystem in Healthcare Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 BioMEMS and Microsystem in Healthcare Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Dynamics
2.3.1 BioMEMS and Microsystem in Healthcare Industry Trends
2.3.2 BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Drivers
2.3.3 BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Challenges
2.3.4 BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top BioMEMS and Microsystem in Healthcare Players by Revenue
3.1.1 Global Top BioMEMS and Microsystem in Healthcare Players by Revenue (2018-2023)
3.1.2 Global BioMEMS and Microsystem in Healthcare Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by BioMEMS and Microsystem in Healthcare Revenue
3.4 Global BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BioMEMS and Microsystem in Healthcare Revenue in 2022
3.5 BioMEMS and Microsystem in Healthcare Key Players Head office and Area Served
3.6 Key Players BioMEMS and Microsystem in Healthcare Product Solution and Service
3.7 Date of Enter into BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 BioMEMS and Microsystem in Healthcare Breakdown Data by Type
4.1 Global BioMEMS and Microsystem in Healthcare Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global BioMEMS and Microsystem in Healthcare Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 BioMEMS and Microsystem in Healthcare Breakdown Data by Application
5.1 Global BioMEMS and Microsystem in Healthcare Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global BioMEMS and Microsystem in Healthcare Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size (2018-2029)
6.2 North America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa BioMEMS and Microsystem in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluechiip
11.1.1 Bluechiip Company Detail
11.1.2 Bluechiip Business Overview
11.1.3 Bluechiip BioMEMS and Microsystem in Healthcare Introduction
11.1.4 Bluechiip Revenue in BioMEMS and Microsystem in Healthcare Business (2018-2023)
11.1.5 Bluechiip Recent Development
11.2 Cepheid
11.2.1 Cepheid Company Detail
11.2.2 Cepheid Business Overview
11.2.3 Cepheid BioMEMS and Microsystem in Healthcare Introduction
11.2.4 Cepheid Revenue in BioMEMS and Microsystem in Healthcare Business (2018-2023)
11.2.5 Cepheid Recent Development
11.3 Given Imaging
11.3.1 Given Imaging Company Detail
11.3.2 Given Imaging Business Overview
11.3.3 Given Imaging BioMEMS and Microsystem in Healthcare Introduction
11.3.4 Given Imaging Revenue in BioMEMS and Microsystem in Healthcare Business (2018-2023)
11.3.5 Given Imaging Recent Development
11.4 Integrated Sensing
11.4.1 Integrated Sensing Company Detail
11.4.2 Integrated Sensing Business Overview
11.4.3 Integrated Sensing BioMEMS and Microsystem in Healthcare Introduction
11.4.4 Integrated Sensing Revenue in BioMEMS and Microsystem in Healthcare Business (2018-2023)
11.4.5 Integrated Sensing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bluechiip
Cepheid
Given Imaging
Integrated Sensing
Ìý
Ìý
*If Applicable.